#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Polycystic liver disease Castleman's disease NTRK gene fusion overexpression Haemolytic uraemic syndrome Acute myeloid leukaemia refractory Atypical haemolytic uraemic syndrome Oesophageal adenocarcinoma stage III Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Blood iron increased Fatty acid oxidation disorder Follicle centre lymphoma follicular grade I II – III refractory Neonatal alloimmune thrombocytopenia Inclusion body myositis Spinal muscular atrophy Peripheral T-cell lymphoma unspecified More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Basic Information Noonan syndrome – Treatment Propionic acidaemia – Life with Disease Osteosarcoma – Trials in Disease Hereditary hypophosphataemic rickets – Diagnostics Haemophilia B without inhibitors – Life with Disease Aicardi-Goutieres syndrome – Treatment Thrombotic thrombocytopenic purpura – Diagnostics Haemophilia – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azd3470 Pal1-15 Acetate Auto4 GRISNILIMAB SETARITOX Sotagliflozin Bt-001 Risperidone IMB 101 Efmoroctocog Alfa TX000045 Danicopan Highly Refined Fish Oil Buparlisib Azetukalner Pozelimab Tislelizumab Ab-729 Metolazone Gadoteric Acid Deoxyribonucleic Acid More therapies…

    Learn about Your Condition

    EGFR gene mutation Chondrosarcoma Pre-eclampsia Acute hepatic failure Multiple sclerosis relapse Mental disorder Pemphigus Dysmenorrhoea Tendon disorder Gender dysphoria Dermatitis Mitochondrial DNA depletion Oesophageal adenocarcinoma Cirrhosis alcoholic H1N1 influenza More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Abemaciclib and Letrozole for Patients with Estrogen Receptor Positive Low-Grade Serous Ovarian Cancer and Adult-Type Granulosa Cell Tumor

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Abemaciclib
    • Letrozole
    Belgium France The Netherlands

  • Study on Tirbanibulin for Treating Superficial Basal Cell Carcinoma in Patients

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Tirbanibulin
    France

  • Study on Prednisolone for Women with Unexplained Recurrent Miscarriages

    Recruiting

    3 1 1
    Investigated Diseases:
    • Habitual abortion
    Investigated Drugs:
    • Prednisolone
    The Netherlands

  • Study on Pregnancy Rates in Women with Polycystic Ovary Syndrome Using Letrozole and Gonadotropins

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Follitropin Alfa
    • Follitropin Alfa (Genetical Recombination)
    • Follitropin Beta
    Spain

  • Study on Radiotherapy and Antiandrogens for Patients with Advanced Prostate Cancer Using Abiraterone Acetate and Enzalutamide

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Enzalutamide
    Spain

  • Study on the Effectiveness of Belumosudil and Azithromycin for Adults with Chronic Lung Rejection After Lung Transplant

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anhydrous Azithromycin
    • Belumosudil Mesilate
    Austria Belgium Czechia Denmark Finland France +8
Previous Page
1 … 536 537 538 539 540 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!